• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

SOC Telemed Acquires Access Physicians for $194M to Form Largest Acute Telemedicine Provider

Share:

April 10, 2021

What You Should Know:

– SOC Telemed, today announced the acquisition of Dallas-based Access Physicians in a deal valued at $194 million in cash and stock to become the largest pure-play provider of acute telemedicine in the country.

– The company will deliver care to almost 1,000 facilities including more than 700 hospitals in 48 states. In addition to an expanded national footprint, this deal will expand clinical service lines including infectious disease, cardiology, maternal-fetal medicine, nephrology, and more in addition to SOC Telemed’s core services of neurology, psychiatry, critical care, and pulmonology.

– SOC’s technology platform, Telemed IQ is the backbone that lets providers securely deploy, optimize and scale telemedicine programs. Together, they offer a comprehensive acute telemedicine portfolio to meet the challenges of a market struggling with physician specialty shortages and inequities in access to specialized care. The ability to offer new clinical service lines for both companies’ existing customers will allow the combined company to meet the demand for a single partner for acute care solutions.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

– The combined company is estimated to have approximately $107-$113 million in pro forma annual revenue in 2021.

Source: Hitconsultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Chinese Startup CareVoice Officially Launches CareVoiceOSChinese Startup CareVoice Officially Launches CareVoiceOS
  • Amwell, Tyto Care Expand Partnership to Power Augmented Virtual Care ExperiencesAmwell, Tyto Care Expand Partnership to Power Augmented Virtual Care Experiences
  • SEC Investigating Illumina’s Multi-Billion Dollar Merger with GRAILSEC Investigating Illumina’s Multi-Billion Dollar Merger with GRAIL
  • LabCorp : and Mount Sinai Health System Collaborate to Establish Digital and AI-Enabled Pathology Center of ExcellenceLabCorp : and Mount Sinai Health System Collaborate to Establish Digital and AI-Enabled Pathology Center of Excellence
  • LifeOmic, Susan G. Komen Tissue Bank Partner to Advance Breast Cancer ResearchLifeOmic, Susan G. Komen Tissue Bank Partner to Advance Breast Cancer Research
  • Growth in the Adoption of 3D Printing Technology After COVID-19 Isn’t A CoincidenceGrowth in the Adoption of 3D Printing Technology After COVID-19 Isn’t A Coincidence
  • BioScrip, Option Care to mergeBioScrip, Option Care to merge
  • Premier Health Enters into Definitive Agreement to Acquire Two Operating Pharmacies in Metro VancouverPremier Health Enters into Definitive Agreement to Acquire Two Operating Pharmacies in Metro Vancouver

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications